Europe’s medical devices industry saw a drop of 14.71% in deal activity during March 2021, when compared with the last 12-month average, led by Hologic’s $159m acquisition of Diagenode, according to GlobalData’s deals database.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 29 medical devices industry deals worth $521.49m were announced for the region in March 2021, against the 12-month average of 34 deals.

Of all the deal types, M&A saw most activity in March 2021 with 15 transactions, representing a 51.7% share for the region.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In second place was venture financing with 13 deals, followed by private equity deals with one transactions, respectively capturing a 44.8% and 3.5% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in Europe’s medical devices industry with $369.59m, while venture financing and private equity deals totalled $101.9m and $50m, respectively.

Europe medical devices industry deals in March 2021: Top deals

The top five medical devices deals accounted for 85.3% of the overall value during March 2021.

The combined value of the top five medical devices deals stood at $444.58m, against the overall value of $521.49m recorded for the month.

The top five medical devices industry deals of March 2021 tracked by GlobalData were:

1) Hologic’s $159m acquisition of Diagenode

2) The $110m acquisition deal with Softhale by Sino Biopharmaceutical

3) DCC Healthcare’s $95.58m acquisition of Worner Medizinprodukte

4) The $50m private equity deal with MedAlliance by Citic Capital Partners

5) Foresite Capital Management, F-Prime, Lansdowne Partners and Oxford Sciences Innovation’s venture financing of Genomics for $30m.